DIVISLAB's weekly return of -1.21% was in line with its peers, with a relatively higher volatility of 23.37%. The stock's Sharpe Ratio of -0.27 indicates a poor risk-adjusted performance. Compared to its peers, DIVISLAB underperformed CIPLA but outperformed DRREDDY and SUNPHARMA in terms of returns. Overall, the stock was relatively riskier this week.

[Volatility: 23.37%]